Fundraising Fox

Redshiftbio

Boxborough, US · Delaware corporation · 2 known investors

redshiftbio.com

Redshift Bio develops real-time monitoring technology for biomolecular structure and concentration analysis in biopharmaceutical development and manufacturing. The platform enables pharmaceutical and biotech companies to make earlier decisions by providing direct structural insights during production processes.

BiotechDeep TechEnterprise Softwarein /redshiftbio@redshiftbio

Founders & leadership

TO
Thomas O'LenicExecutive Officer, Director
EM
Eugene MaExecutive Officer
CM
Charles MarshallExecutive Officer, Director
FS
Frank SmithDirector
WC
William CadoganDirector
BH
WM
SH
Susan HolleranDirector

Investors · 2

Reported raises · per SEC filings

Form D private placements
$5.9MraisedJun 2025 · 8 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank SmithDirector
  • William CadoganDirector
  • Bryson HollimonDirector
  • Susan HolleranDirector
  • Wouter MeulemanDirector
  • Thomas O'LenicExecutive Officer, Director
Offering amount
$7.1M
Amount sold
$5.9M
First sale
Jun 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$5MraisedApr 2024 · 6 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bryson HollimonDirector
  • Mark CafazzoDirector
  • William CadoganDirector
  • Wouter MeulemanDirector
  • Thomas O'LenicExecutive Officer, Director
  • Frank SmithDirector
  • Amol ChaubalDirector
Offering amount
$7M
Amount sold
$5M
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$10MraisedOct 2021 · 12 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles PurtellDirector
  • Julien BradleyExecutive Officer, Director
  • Bryson HollimonDirector
  • William CadoganDirector
  • Frank SmithDirector
  • Amol ChaubalDirector
Offering amount
$20M
Amount sold
$10M
Sales commissions
$275K
Placement agents
Bowen Advisors Inc.
First sale
Oct 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$6.4MraisedDec 2020 · 6 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles PurtellDirector
  • William CadoganDirector
  • Frank SmithDirector
  • Julien BradleyExecutive Officer, Director
  • Bryson HollimonDirector
  • Rob CarsonDirector
Offering amount
$6.4M
Amount sold
$6.4M
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$18.3MraisedDec 2019 · 11 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • William CadoganDirector
  • Charles MarshallExecutive Officer, Director
  • Rob CarsonDirector
  • Eugene MaExecutive Officer
  • Bryson HollimanDirector
  • Frank SmithDirector
Offering amount
$18.3M
Amount sold
$18.3M
First sale
Sep 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$10.8MraisedMar 2017 · 10 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Eugene MaExecutive Officer
  • Frank SmithDirector
  • William CadoganDirector
  • Bryson HollimanDirector
  • Charles MarshallExecutive Officer, Director
Offering amount
$10.8M
Amount sold
$10.8M
Sales commissions
$250K
Placement agents
Bowen Advisors, Inc.
First sale
Feb 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$998.1KraisedOct 2015 · 4 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank SmithDirector
  • Eugene MaExecutive Officer
  • William CadoganDirector
  • Charles MarshallExecutive Officer, Director
  • Bryson HollimonDirector
Offering amount
$2M
Amount sold
$998.1K
Minimum investment
$1
Proceeds to insiders
$50.5K
First sale
Sep 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.